BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30449207)

  • 1. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
    Rehfeld JF; Knop FK; Asmar A; Madsbad S; Holst JJ; Asmar M
    Scand J Gastroenterol; 2018 Dec; 53(12):1429-1432. PubMed ID: 30449207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
    Rohde U; Sonne DP; Christensen M; Hansen M; Brønden A; Toräng S; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2016 May; 101(5):2076-83. PubMed ID: 27003305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Albiglutide on Cholecystokinin-Induced Gallbladder Emptying in Healthy Individuals: A Randomized Crossover Study.
    Shaddinger BC; Young MA; Billiard J; Collins DA; Hussaini A; Nino A
    J Clin Pharmacol; 2017 Oct; 57(10):1322-1329. PubMed ID: 28543352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?
    Rehfeld JF; Knop FK; Asmar M
    Scand J Gastroenterol; 2019 Dec; 54(12):1448-1451. PubMed ID: 31725337
    [No Abstract]   [Full Text] [Related]  

  • 5. New Avenues in the Regulation of Gallbladder Motility-Implications for the Use of Glucagon-Like Peptide-Derived Drugs.
    Gether IM; Nexøe-Larsen C; Knop FK
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2463-2472. PubMed ID: 30137354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
    Keller J; Trautmann ME; Haber H; Tham LS; Hunt T; Mace K; Linnebjerg H
    Regul Pept; 2012 Nov; 179(1-3):77-83. PubMed ID: 22960288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
    Brønden A; Albér A; Rohde U; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4153-4162. PubMed ID: 28938439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
    Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
    Brønden A; Albér A; Rohde U; Gasbjerg LS; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2018 Feb; 20(2):362-369. PubMed ID: 28786523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
    MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
    Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
    Shirohara H; Tabaru A; Otsuki M
    J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study.
    Hansen NL; Brønden A; Nexøe-Larsen CC; Christensen AS; Sonne DP; Rehfeld JF; Wever Albretchsen NJ; Hartmann B; Vilsbøll T; Holst JJ; Knop FK
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00257. PubMed ID: 33512799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man.
    de Boer SY; Masclee AA; Jebbink MC; Schipper J; Jansen JB; Lamers CB
    JPEN J Parenter Enteral Nutr; 1992; 16(1):16-9. PubMed ID: 1738213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes.
    Ahrén B; Holst JJ; Efendic S
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1043-8. PubMed ID: 10720037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of feeding fat or intrajugular infusion of glucagon-like peptide-1 and cholecystokinin on dry matter intake, digestibility, and digesta rate of passage in growing wethers.
    Relling AE; Reynolds CK; Loerch SC
    J Anim Sci; 2011 Jan; 89(1):168-78. PubMed ID: 21178181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Age on Blood Glucose and Plasma Insulin, Glucagon, Ghrelin, CCK, GIP, and GLP-1 Responses to Whey Protein Ingestion.
    Giezenaar C; Hutchison AT; Luscombe-Marsh ND; Chapman I; Horowitz M; Soenen S
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29267221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
    Gether IM; Bahne E; Nerild HH; Rehfeld JF; Hartmann B; Holst JJ; Vilsbøll T; Sonne DP; Knop FK
    Eur J Endocrinol; 2024 Mar; 190(4):314-326. PubMed ID: 38551029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.